Showing results (1-10 of 404) with videos related to
Sort By:
Pageof 41
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 2, 2017
[New Treatment Options for Renal Cell Carcinoma - Efficacy and Safety of Immune Checkpoint Inhibitors]Masatoshi EtoInternational Journal of Clinical Oncology|July 20, 2006
Molecular targeting therapy for renal cell carcinomaMasatoshi Eto, Seiji NaitoInternational Journal of Urology : Official Journal of the Japanese Urological Association|April 11, 2016
Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancerMasaki Shiota, Masatoshi EtoGan to Kagaku Ryoho. Cancer & Chemotherapy|October 31, 2002
[Cytokine therapy for metastatic renal cell carcinoma]Masatoshi Eto, Seiji NaitoNihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2014
[Current status and prospects of immunotherapy for castration-resistant prostate cancer]Junji Yatsuda, Masatoshi EtoCancer Management and Research|June 14, 2019
Profile of pembrolizumab in the treatment of patients with unresectable or metastatic urothelial carcinomaJunichi Inokuchi, Masatoshi EtoCancers|September 9, 2022
Active Surveillance in Intermediate-Risk Prostate Cancer: A Review of the Current DataLeandro Blas, Masaki Shiota, Masatoshi EtoNeurourology and Urodynamics|May 3, 2018
Long-term urodynamic follow-up after external sphincterotomy in patients with spinal cord injuryRyosuke Takahashi, Yasusuke Kimoto, Masatoshi EtoCancers|June 10, 2022
Current Status and Future Perspective on the Management of Lymph Node-Positive Prostate Cancer after Radical ProstatectomyMasaki Shiota, Leandro Blas, Masatoshi EtoCancer Treatment and Research Communications|July 14, 2022
Current status and future perspective on the management of metastatic castration-sensitive prostate cancerLeandro Blas, Masaki Shiota, Masatoshi EtoPageof 41